Results 41 to 50 of about 553 (159)
Optimal precurarizing dose of rocuronium to decrease fasciculation and myalgia following succinylcholine administration [PDF]
Korean Journal of Anesthesiology, 2014 BackgroundSuccinylcholine commonly produces frequent adverse effects, including muscle fasciculation and myalgia. The current study identified the optimal dose of rocuronium to prevent succinylcholine-induced fasciculation and myalgia and evaluated the ...
Kyu Nam Kim +4 more
doaj +1 more source
Neuromuscular block in patients 80 years and older: a prospective, controlled study
BMC Anesthesiology, 2021 Background An increasing number of patients older than 80 years are undergoing anesthesia, but little information is available regarding pharmacodynamic effects of myorelaxants in this population.
Denis Schmartz +4 more
doaj +1 more source
Influence of obstructive jaundice on pharmacodynamics of rocuronium. [PDF]
PLoS ONE, 2013 BACKGROUND:Anesthetics are variable in patients with obstructive jaundice. The minimum alveolar concentration awake of desflurane is reduced in patients with obstructive jaundice, while it has no effect on pharmacodynamics and pharmacokinetics of ...
Zhen-Meng Wang +5 more
doaj +1 more source
Influence of methylprednisolone on the reversal time of sugammadex: a randomized clinical trial [PDF]
Revista Brasileira de Anestesiologia, 2020 Background and objectives: Sugammadex is a modified gamma-cyclodextrin that reverses the effects of aminosteroidal neuromuscular blocking agents.
Merve Hayriye Kocaoğlu +3 more
doaj +3 more sources
Effect of dexamethasone on the onset time and recovery profiles of cisatracurium [PDF]
Korean Journal of Anesthesiology, 2017 BackgroundThe effect of dexamethasone injection on cisatracurium-induced neuromuscular block was compared according to different injection time points.MethodsOne hundred seventeen patients were randomly assigned to three groups: 8 mg of dexamethasone ...
Keum Young So +3 more
doaj +1 more source
Error Traps in Pediatric Neuromuscular Block
Pediatric Anesthesia, Volume 36, Issue 8, Page 887-898, August 2026.ABSTRACT Background Neuromuscular blocking agents are essential for safe pediatric anesthesia but remain a frequent source of preventable morbidity when misused, inadequately monitored, or incompletely reversed. Children, particularly neonates and infants, are especially vulnerable to residual neuromuscular block due to developmental pharmacological ...
Gabriel Soares de Sousa +5 more
wiley +1 more source
Pediatric Anesthesia, Volume 36, Issue 8, Page 983-988, August 2026.ABSTRACT Background Neostigmine is widely used to reverse nondepolarizing neuromuscular blockade in children, but the optimal dose under total intravenous anesthesia is uncertain. Aims The primary aim was to compare the time to full neuromuscular recovery (TOF ratio of 1.0) following administration of neostigmine at doses of 0, 10, 20, and 30 μg/kg in ...
Antonio J. M. M. Neto +7 more
wiley +1 more source
BioengineeringQuantitative neuromuscular monitoring, as extolled by clinical guidelines, is advocated to circumvent the complications associated with neuromuscular blockers (NMBs), such as residual neuromuscular block (rNMB).
Yanjie Dong +3 more
doaj +1 more source
Acta Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.ABSTRACT Background Routine use of neuromuscular blocking agents (NMBAs) is widely recommended to facilitate tracheal intubation. However, NMBA use is associated with potential adverse effects, including postoperative respiratory complications, intraoperative awareness and anaphylaxis.
Emil Ørskov Ipsen +19 more
wiley +1 more source
Progress towards a standard of quantitative twitch monitoring
, 2020 Anaesthesia, Volume 75, Issue 9, Page 1133-1135, September 2020.
A. Bowdle, S. Jelacic
wiley +1 more source